Claim Missing Document
Check
Articles

Found 2 Documents
Search

Gambaran Karakteristik Pasien Erupsi Obat Alergi di RSUD Arifin Achmad Pekanbaru Periode 2010 – 2014 Endang H Darmani; T.Sy. Dessi Indah S As; Yuni Eka Anggraini; Olivia Makmur
Jurnal Ilmu Kedokteran Vol 10, No 1 (2016): Jurnal Ilmu Kedokteran
Publisher : Fakultas Kedokteran Universitas Riau

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (31.385 KB) | DOI: 10.26891/JIK.v10i1.2016.67-70

Abstract

Allergic drug eruptions is one of most dermatology cases can find in Arifin Achmad General Hospital Pekanbaru forlast four years and study about the characteristic description of allergic drug eruption’s patients never been describedbefore. To describe the characteristic of allergic drug eruption’s patients in Arifin Achmad General Hospital PekanbaruIndonesia. This is a descriptive retrospective study with 35 subjects, which is describing the most common type ofmorphologic skin eruption, groups of gender and age were affected , and etiology drugs were suspected. Mostcommon type of morphologic skin eruption is exfoliative dermatitis (eritroderma) (42,8%), most frequently genderaffected is women (60%) and group of age most frequenly affected is 41-50 (25.7%) years old. Antibiotics is the mostcauses were suspected (60%). Exfoliative dermatitis, women and age 41-50 years old were most common characteristicdescription of allergic drug eruption’s patients in Arifin Achmad general Hospital Pekanbaru time periode 2010-2014.
Ko-infeksi Human Immunodeficiency Virus (HIV) dengan Mycobacterium leprae Yuni Eka Anggraini
Jurnal Ilmu Kedokteran Vol 9, No 1 (2015): Jurnal Ilmu Kedokteran
Publisher : Fakultas Kedokteran Universitas Riau

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (34.442 KB) | DOI: 10.26891/JIK.v9i1.2015.1-6

Abstract

Human immunodefficiency virus (HIV) epidemic covers several countries with endemic leprosy without any significantincrease in the number of patients co-infected with HIV and leprosy, so it can be concluded that HIV-positive does notincrease the risk of developing leprosy. Clinicopathological spectrum of leprosy patients who are co-infected withHIV is not changed. Leprosy may be attributed to the presence of immune recovery syndrome after the administrationof highly active antiretroviral therapy (HAART). Long-term incubation period and the low incidence of leprosy inpatients with HIV make prospective cohort or case-control studies on the prevalence of leprosy among a group of HIVpositive and HIV negative hardly possible to be performed. The benefit of this circumstance is the HIV pandemicdoes not become a nuisance of the effort to control leprosy. Further studies on the molecular pathogenesis of M.leprae and other mycobacterial can provide an understanding of the differences of the pathogenesis in patients withHIV infection.